EVIDENCE HEATMAP / CARDIAC CLUSTER
TB-500 Cardiac Research: Thymosin Beta-4, Epicardial Progenitors, and Post-Infarct Repair
The hottest cluster in the literature — and the one that most needs its parent-protein mark. The cardiac case is built almost entirely on full-length thymosin beta-4, with the genuine findings and the null results both on the record.
The survival pathway: PINCH-ILK-Akt
TB-500 cardiac research traces back to a 2004 Nature finding. In mice, thymosin beta-4 formed a functional complex with PINCH and integrin-linked kinase (ILK), activating the survival kinase Akt; it promoted cardiac and endothelial cell migration, and after coronary artery ligation it upregulated ILK and Akt, enhanced early myocyte survival, and improved cardiac function [2]. This is the mechanistic anchor of the cardiac story — a defined survival-signaling pathway, not a vague "heart benefit."
The sequence matters. The same actin-binding protein that buffers the cytoskeleton also, in cardiac tissue, recruits a kinase complex that switches on a pro-survival program. Akt activation is one of the better-characterized routes by which a cell resists apoptosis after ischemic stress, so a molecule that reliably engages it in injured myocardium is a coherent regeneration candidate — which is precisely why this finding seeded more than a decade of follow-up work.
The parent-protein mark belongs on every sentence of this page. These are findings for full-length thymosin beta-4 (~4963 Da), the protein from which TB-500 carries only the actin-binding fragment. Whether the 889 Da heptapeptide reproduces PINCH-ILK-Akt activation in humans is unproven, and there is no completed controlled cardiac trial of the fragment. On the heatmap, the cardiac survival cell is hot — and it is also flagged parent-protein, because the heat is borrowed from the whole molecule, not demonstrated for the 7-mer.
Epicardial progenitors and neovascularization
Beyond cell survival, thymosin beta-4 reactivates a developmental program in the adult heart. In mice, it induced adult epicardial progenitor cell mobilization and neovascularization of ischemic myocardium [7] — re-running an embryonic process to rebuild vasculature. The epicardium, the heart's outer layer, harbors progenitor cells that are largely quiescent in the adult; the finding was that Tβ4 can wake them, and that the mobilized cells contribute to new vessel formation in damaged tissue.
The developmental basis is consistent. Tβ4 was identified as an essential paracrine factor of embryonic endothelial progenitor cells, supporting coronary vessel development [8] — the same role in building the embryonic coronary tree that it appears to partially restage in the injured adult heart. A 2010 review draws these threads together, summarizing the protein's protective and regenerative mechanisms across the cardiac models [10].
This epicardial-progenitor mechanism is part of why the cardiac cluster runs hot in the preclinical band. It is also a clean example of borrowed heat — both findings are full-length Tβ4 in mice, not the TB-500 fragment in humans, and neither has been reproduced for the heptapeptide in a controlled human study.
Post-infarct repair: genuine findings and the null results
Thymosin beta-4 was reported cardioprotective after myocardial infarction in rodent models, reducing injury and supporting cardiac function [9]. The most recent large-animal data add a qualified positive: a 2021 porcine study using engineered delivery found that Tβ4 increased cardiac cell proliferation and engraftment and enhanced the reparative potency of co-delivered mesenchymal stromal cells [12]. That is meaningful — pigs are a far better cardiac model for humans than mice — but it is a positive with an assist, achieved alongside a cell therapy and a delivery system rather than by the peptide alone.
The honest counterweight is on the same record. Systemic thymosin beta-4 failed to attenuate myocardial ischemia-reperfusion injury in a separate porcine study, and in dystrophin-deficient mice it did not improve cardiac function despite increasing the number of regenerating fibers [5]. Two pig studies pointing in opposite directions, and a mouse model where a structural effect did not translate to a functional one, is the real texture of this literature. The cardiac signal is real in parts and null in others — which is exactly why it is graded, not asserted, and why the warmest cells on this page still sit next to cold ones.
Why the cardiac signal is read first here
This page leads the site because the cardiac literature is the strongest concentration of mechanism, replication, and large-animal follow-through in the whole thymosin beta-4 record — and because that strength is exactly what makes the borrowed-heat problem worth stating loudly. A reader who arrives looking for TB-500's effect on the heart should leave knowing two things at once: that there is a genuine, decade-deep preclinical case for the parent protein, and that essentially none of it has been demonstrated for the 889 Da fragment sold as TB-500.
The gap between those two facts is not a technicality. The cardiac findings — PINCH-ILK-Akt survival signaling [2], epicardial-progenitor mobilization [7], the embryonic paracrine role [8], post-infarct cardioprotection [9] — were obtained with full-length thymosin beta-4. The actin-binding LKKTETQ motif that TB-500 carries is necessary to some of the protein's activity, but it is not the whole molecule, and the N-terminal Ac-SDKP fragment with its own anti-fibrotic and angiogenic activity is not even generated by the C-terminal-region TB-500 sequence. Reproducing a multi-domain protein's cardiac program with one of its motifs is a hypothesis, not a result.
The honest bottom line on the heart
The cardiac case for thymosin beta-4 is real, animal-confirmed, and unusually mechanistic for a regenerative peptide — and it remains entirely preclinical, mixed at the edges, and unproven for the TB-500 fragment in humans. A 2026 narrative review placed TB-500 and thymosin beta-4 among unapproved peptides that show favorable tissue-repair outcomes in animal models while rigorous human safety data stay scarce and the compounds operate largely outside regulatory oversight [11].
On this site's grading, the cardiac cluster is where the heat is hottest and the parent-protein flag is most necessary at the same time. That is the whole point of reading it as a heatmap rather than a headline: the intensity is honest, and so is the source of it.